http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011035024-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_633d0ab84d9a7768f3590fbce9fcc722 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e81a3a9a825708abc36da72a789846a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_766b5115ec3841172ab753aa36222250 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-12 |
| filingDate | 2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b3c339617dff2abc1496def871f72a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0858733c3eabeddeebff2c77381a1ecb |
| publicationDate | 2011-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2011035024-A2 |
| titleOfInvention | Unsealed, non-colloidal radiopharmaceutical compositions and methods for treatment of abnormal tissue |
| abstract | The present disclosure relates, according to some embodiments, to compositions and methods for treatment of an abnormal tissue (e.g., cancer). For example, a method may comprise administering to a subject in the region of the abnormal tissue a composition (e.g., a pharmaceutical and/or radiopharmaceutical composition) having a basic pH (e.g., greater than about 9). A radiopharmaceutical composition may comprise, in some embodiments, an admixture of (a) a first radionuclide composition comprising an unsealed, non-colloidal, radioactive, free holmium-166 ( 166 Ho) and/or unsealed, non-colloidal, radioactive, free metal ion of holmium-166 ( 166 Ho) (e.g., 166 Ho 3+ ) and (b) a second radionuclide composition comprising an unsealed, non-colloidal, radioactive, free lutetium- 177 ( 177 Lu) and/or an unsealed, non-colloidal, radioactive, free metal ion of lutetium-177 ( 177 Lu) (e.g., 177 Lu 3+ ). A radiopharmaceutical composition may comprise, in some embodiments, an unsealed, non- colloidal, radioactive, free metal and/or metal ion (e.g., antimony- 126, antimony- 127, cesium- 132, europium- 136, gadolinium- 159, lutetium-177, phosphorous-32, promethium- 148, promethium-149, rubidium-86, strontium-89, tin- 125, ytterbium- 175, and/or ions thereof). |
| priorityDate | 2009-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 121.